CompletedPhase 3NCT00344253

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Studying Intermediate uveitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Heidelberg University
Principal Investigator: Matthias D Becker, MD, PhD,FEBO
Interdisciplinary Uveitis Center, University of Heidelberg
Intervention: Interferon beta(drug)
Enrollment: 19 enrolled
Eligibility: 18 years · All sexes
Timeline: 2006 – 2012

Study locations (1)

Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany

Collaborators

Serono GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00344253 on ClinicalTrials.gov

← Back to all trials